Literature DB >> 21323359

HIV-1 IN strand transfer chelating inhibitors: a focus on metal binding.

Alessia Bacchi1, Mauro Carcelli, Carlotta Compari, Emilia Fisicaro, Nicolino Pala, Gabriele Rispoli, Dominga Rogolino, Tino W Sanchez, Mario Sechi, Nouri Neamati.   

Abstract

Most active and selective strand transfer HIV-1 integrase (IN) inhibitors contain chelating functional groups that are crucial feature for the inhibition of the catalytic activities of the enzyme. In particular, diketo acids and their derivatives can coordinate one or two metal ions within the catalytic core of the enzyme. The present work is intended as a contribution to elucidate the mechanism of action of the HIV-IN inhibitors by studying the coordinative features of H₂L¹ (L-708,906), an important member of the diketo acids family of inhibitors, and H₂L₂, a model for S-1360, another potent IN inhibitor. Magnesium(II) and manganese(II) complexes of H₂L¹ and H₂L² were isolated and fully characterized in solution and in the solid state. The crystal structures of the manganese complex [Mn(HL₂)₂(CH₃OH)₂]·2CH₃OH were solved by X-ray diffraction analysis. Moreover, the speciation models for H₂L₂ with magnesium(II) and manganese(II) ions were performed and the formation constants of the complexes were measured. M(HL₂)₂ (M = Mg²+, Mn²+) was the most abundant species in solution at physiological pH. All the synthesized compounds were tested for their anti-IN activity, showing good results both for the ligand and the corresponding complexes. From analysis of the speciation models and of the biological data we can conclude that coordination of both metal cofactors could not be strictly necessary and that inhibitors can act as complexes and not only as free ligands.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21323359     DOI: 10.1021/mp100343x

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  5 in total

1.  HIV Drug Resistance and the Advent of Integrase Inhibitors.

Authors:  Peter K Quashie; Thibault Mesplède; Mark A Wainberg
Journal:  Curr Infect Dis Rep       Date:  2013-02       Impact factor: 3.725

2.  Rapid activity prediction of HIV-1 integrase inhibitors: harnessing docking energetic components for empirical scoring by chemometric and artificial neural network approaches.

Authors:  Patcharapong Thangsunan; Sila Kittiwachana; Puttinan Meepowpan; Nawee Kungwan; Panchika Prangkio; Supa Hannongbua; Nuttee Suree
Journal:  J Comput Aided Mol Des       Date:  2016-06-17       Impact factor: 3.686

Review 3.  The Need for Development of New HIV-1 Reverse Transcriptase and Integrase Inhibitors in the Aftermath of Antiviral Drug Resistance.

Authors:  Mark A Wainberg
Journal:  Scientifica (Cairo)       Date:  2012-12-31

Review 4.  Integrase Inhibitor Prodrugs: Approaches to Enhancing the Anti-HIV Activity of β-Diketo Acids.

Authors:  Vasu Nair; Maurice Okello
Journal:  Molecules       Date:  2015-07-13       Impact factor: 4.411

5.  Expanding the chemical space of 3(5)-functionalized 1,2,4-triazoles.

Authors:  Dmytro M Khomenko; Roman O Doroshchuk; Yulia M Ohorodnik; Hanna V Ivanova; Borys V Zakharchenko; Ilona V Raspertova; Oleksandr V Vaschenko; Alexey V Dobrydnev; Oleksandr O Grygorenko; Rostyslav D Lampeka
Journal:  Chem Heterocycl Compd (N Y)       Date:  2022-03-23       Impact factor: 1.490

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.